These endocrine-disrupting chemicals included BPA and phthalates — compounds found in plastics, food packaging, personal care products, medical devices, and hundreds of other everyday items. The concerning part wasn’t acute poisoning. It was that they interfered with hormone signaling at vanishingly small concentrations, with the most sensitive windows being prenatal development, infancy, and puberty — precisely the developmental stages where hormone regulation is most critical and most irreversible.
The scientific understanding of BPA and phthalates has advanced dramatically since those early aquatic studies, and the picture that’s emerged is detailed but concerning. These aren’t chemicals that will harm anyone through a single exposure. They’re chemicals that act on the body’s most sensitive regulatory system — endocrinology — through chronic, lifelong exposure from a remarkable diversity of daily sources. Understanding those sources and reducing them is both actionable and evidence-supported.
BPA: The Plastic Hardener With Hormonal Activity
Bisphenol A is a synthetic estrogen discovered in the 1930s during a search for compounds mimicking estrogen for pharmaceutical use. It was never used as a pharmaceutical — other synthetic estrogens proved more potent — but found enormous commercial application as a hardening agent for polycarbonate plastic and as a component of epoxy resins lining food and beverage cans. Global BPA production now exceeds 10 billion pounds annually.
BPA’s estrogen-mimicking properties became a concern once research showed BPA leaching from polycarbonate plastics and epoxy can linings into food and beverages at temperatures typically encountered in use. The biomonitoring data is striking: BPA has turned up in urine samples of over 93% of the US population tested in NHANES studies, establishing near-universal exposure. It’s also been detected in amniotic fluid, umbilical cord blood, placental tissue, and breast milk — confirming fetal and neonatal exposure during the most vulnerable developmental windows there are.
Human research associations include: higher urinary BPA and obesity in children and adults; higher BPA and insulin resistance and type 2 diabetes risk; higher prenatal BPA and behavioral and attention problems in children; associations with cardiovascular disease markers in adults; and potential reproductive effects in both men, including reduced sperm quality, and women, including altered menstrual cycle. None of this proves causation on its own — observational epidemiology has confounders — but the associations are consistent across multiple independent research groups and line up with the biological mechanisms established in extensive animal research.
The regulatory response to BPA has been incomplete. The FDA banned BPA from baby bottles and sippy cups in 2012 and from infant formula packaging in 2013 — responding to market forces as much as regulatory science, since manufacturers had largely already removed BPA voluntarily. BPA remains approved for adult food contact materials, including the epoxy lining of canned foods and beverages — one of the highest daily exposure sources in the US population, still. The European Food Safety Authority completed a reassessment of BPA in 2023 and dramatically lowered its tolerable daily intake, effectively concluding that current average European exposure exceeds levels considered safe — a conclusion with significant implications for BPA food contact approvals going forward.
BPA-Free Plastics: Not the Solution Many Think
The BPA-free marketing movement was supposed to solve the problem. It largely hasn’t. When manufacturers replaced BPA in plastics, they turned to structural analogs — BPS, BPF, BPAF among others. These replacement bisphenols are also estrogenic in many studies, comparable to or more potent than BPA, also present in the urine of people using BPA-free products, and backed by substantially less safety data than BPA has.
A 2011 study in Environmental Health Perspectives tested 455 commercially available plastics — including many marketed as BPA-free — and found that 70% leached chemicals with estrogenic activity under normal use conditions, rising to over 95% under stress conditions like microwave heating, UV light, or autoclaving. The specific estrogenic compounds weren’t always identified. The estrogenic activity showed up regardless of BPA-free status.
The fundamental issue isn’t specifically BPA — it’s that the whole category of polycarbonate-like plastics has inherent chemical instability producing estrogenic breakdown products under use conditions. “BPA-free” labeling has reassured consumers while potentially exposing them to inadequately tested replacements. The precautionary solution — glass, stainless steel, and ceramic instead of plastic for food contact — sidesteps the entire category of concern rather than trading one problematic compound for an unstudied replacement. This pattern of regrettable substitution, where one problematic compound gets replaced by a structurally similar problematic compound without adequate prior safety assessment, is one of the defining failures of the current chemicals management framework.
Phthalates: The Plasticizers Everywhere
Phthalates are a family of diester compounds used as plasticizers — they make PVC and other hard plastics flexible and durable. They’re the reason a shower curtain is flexible, medical IV tubing is pliable, artificial leather is soft, and vinyl flooring doesn’t shatter underfoot. Global phthalate production exceeds 8 billion pounds annually.
Phthalates also show up in personal care products, where fragrance formulations use them as solvents and fixatives; in adhesives, detergents, solvents, lubricants; and in pharmaceutical tablet coatings. Detectable in the urine of virtually everyone tested in the US — NHANES data shows phthalate metabolites in 99%-plus of study participants — reflecting truly universal exposure from just how pervasive PVC and fragrance are in modern life.
Unlike BPA, phthalates don’t primarily act as estrogens — they’re primarily anti-androgens, interfering with androgen including testosterone signaling. Research in male rodents showed that phthalate exposure during the masculinization programming window of fetal development produced a “phthalate syndrome” including undescended testes, hypospadias, reduced anogenital distance, and infertility. These effects occurred at fetal exposures comparable to those measured in pregnant American women — raising concern about human relevance that has driven regulatory attention and litigation against major phthalate producers.
In human research, several phthalate metabolites measured in maternal urine during pregnancy have been associated with shorter anogenital distance in infant boys — a measure of prenatal androgen exposure; reduced testosterone levels in adult men; reduced sperm quality and quantity; earlier puberty timing in girls; and behavioral effects in children. NHANES data shows near-universal phthalate exposure across the US population, with metabolites detected in over 99% of urine samples tested. That near-universality makes individual case studies of phthalate harm impossible to point to, while making population-level effects statistically detectable across large studies.
The European Union has regulated certain high-concern phthalates far more aggressively than the US — prohibiting DEHP, DBP, BBP, and DIBP in articles above 0.1% concentration under the REACH regulation. The US has banned certain phthalates in children’s toys but lacks comprehensive food contact or personal care product restrictions comparable to European regulations. This regulatory divergence means European consumers face substantially lower phthalate exposures from the same product categories — a difference reflected in biomonitoring studies showing lower phthalate metabolite levels in European populations compared to American ones.
Endocrine Disruption: How BPA and Phthalates Interfere With Hormones
Understanding why BPA and phthalates cause concern at concentrations far below classic toxicological thresholds requires understanding the endocrine system’s remarkable sensitivity. Hormones operate at picomolar to nanomolar concentrations — one part per trillion to one part per billion in blood — and cells are exquisitely sensitive to small changes in hormonal signaling. That sensitivity is a feature, not a bug. It’s what lets hormones coordinate complex developmental programs across billions of cells simultaneously. It also means chemical mimics or disruptors at seemingly tiny concentrations can produce significant biological effects.
BPA acts primarily as an estrogen receptor agonist — it binds estrogen receptors and triggers downstream signaling the cell interprets as estrogen stimulation. At typical environmental exposure levels, BPA’s affinity for classical estrogen receptors is low, roughly 10,000 times weaker than estradiol, but it also activates membrane-bound estrogen receptors (ERα36, GPER) at much lower concentrations and with different downstream signaling characteristics. Research by Frederick vom Saal and colleagues established that BPA in the parts-per-billion range — within typical human exposure levels — produces biological effects in cell culture and animal systems through these non-classical receptor pathways.
Phthalates’ anti-androgenic effects operate primarily through inhibition of testosterone synthesis rather than receptor binding. Phthalates suppress fetal Leydig cell activity — the cells responsible for testosterone production in the developing testis — reducing testosterone levels during the critical masculinization programming window. They also inhibit steroidogenic enzymes in the adrenal gland. The net effect is reduced androgen signaling during development that can produce lasting changes in reproductive system development, sperm production, and hormone levels in adulthood.
The concept of low-dose effects — where endocrine disruptors show effects at low concentrations that disappear at higher concentrations — is one of the most contested and biologically important aspects of this whole field. Classical toxicology assumes a linear dose-response relationship: more exposure equals more effect. Research on endocrine disruptors has repeatedly found non-monotonic dose-response curves, where low doses produce effects that intermediate doses don’t, because the hormone receptors activated at low doses get saturated and downregulated at higher doses. Biologically plausible given how receptor systems function. But it challenges the traditional risk assessment paradigm, and regulatory agencies accustomed to linear dose-response assumptions have resisted it.
Major Exposure Sources for BPA
Canned food and beverages: the epoxy resin lining of metal cans is a significant BPA source for regular canned food consumers. Research has found that a single serving of canned soup raises urinary BPA roughly 1,000% above baseline. The acidic, heat-processed nature of many canned foods accelerates BPA migration from the can lining into the food. BPA-free canned foods are increasingly available but may use BPS or acrylic-based alternatives with less safety data behind them. Glass-jarred alternatives are the most reliably low-BPA option for preserved foods.
Polycarbonate plastic containers marked with recycling code #7 are common in older reusable water bottles, food storage containers, and some plates. Hot liquids, acidic foods, and repeated washing all increase BPA leaching. Swapping polycarbonate food and beverage containers for glass, stainless steel, or ceramic eliminates this route entirely.
Thermal receipt paper — cash register receipts, ATM receipts, pharmacy receipts — uses a thermal coating that typically contains BPA or BPS at high concentration. Research shows BPA from thermal paper absorbs through skin contact, particularly when hands carry lotions or sanitizers that enhance penetration. Brief, minimal handling and hand washing afterward reduces exposure. Opt for electronic receipts where available — one of the simplest and most effective BPA reduction actions there is, and it costs nothing.
Dental sealants and some dental composites use BPA-based compounds, with release highest in the 24 hours after application. The cavity-prevention benefit of sealants likely outweighs the short-term BPA exposure for most patients; BPA-free dental materials exist and are worth requesting, particularly for children receiving multiple sealants.
Major Exposure Sources for Phthalates
Phthalate exposure routes are more diverse than BPA’s, requiring a broader approach that addresses multiple product categories at once.
Fragrance products: “Fragrance” or “parfum” on an ingredient list is a legally protected trade secret designation that can represent dozens to hundreds of unlisted chemicals — a significant share of them phthalates used as fragrance fixatives and solvents. Research has shown phthalate metabolite increases in urine following application of scented personal care products. Synthetic fragrance in lotions, shampoo, conditioner, cologne, perfume, body wash, air fresheners, fabric softeners, and dryer sheets represents one of the most significant phthalate exposure routes for many people — and the one most completely eliminated by choosing fragrance-free alternatives.
Soft PVC products including shower curtains, vinyl flooring, vinyl wallpaper, inflatable toys, raincoats, garden hoses, artificial leather upholstery, and many flexible plastic products contain high concentrations of phthalate plasticizers. These migrate out of the plastic over time, particularly at elevated temperatures, and absorb through skin contact and inhalation. Replacing soft PVC items with phthalate-free alternatives — PEVA shower curtains, hard flooring, fabric upholstery — is a meaningful reduction in the home.
Food packaging: phthalates migrate from packaging materials, particularly for high-fat and hot foods in contact with PVC-containing packaging, into the food itself. Research has found phthalate contamination in cheeses, meats, and other fatty foods packaged in PVC-containing wrap. Buying cheese and deli meats to wrap at home, or requesting deli paper instead of PVC wrap, reduces this exposure. Pizza is a specific area of concern — pizza box cardboard sometimes contains phthalates that migrate into the hot, fatty pizza sitting on top of it.
Medical tubing and devices: PVC medical tubing uses DEHP as a plasticizer, and DEHP leaches into infusions and blood products at concentrations that concern researchers given the vulnerability of hospitalized patients. Largely outside individual control for acute medical care, but DEHP-free alternative devices exist and may be worth requesting for planned procedures, particularly for newborns, infants, and pregnant women.
The Practical Reduction Protocol
Reducing BPA and phthalate exposure doesn’t require eliminating all plastic. It requires identifying the highest-exposure routes and making targeted substitutions where the exposure reduction is highest and the inconvenience is lowest.
Kitchen priorities: replace plastic food storage with glass or stainless steel. Never microwave food in plastic containers — heat dramatically accelerates chemical migration from plastic into food. Filter drinking water and use glass or stainless steel bottles. Reduce canned food consumption; prioritize glass-jarred, frozen, or fresh alternatives. When using canned foods, choose brands explicitly labeled BPA-free and, where possible, with documented alternative liner information.
Personal care priorities: switch to fragrance-free products — shampoo, conditioner, lotion, soap — without “fragrance” or “parfum” on the ingredient list. This single change eliminates a major phthalate exposure source applied directly to skin, daily. Look for products certified by the Environmental Working Group’s Skin Deep database or by third-party organizations like EWG Verified, MADE SAFE, or NSF Cosmos Organic.
Home environment priorities: replace a PVC shower curtain with PEVA, fabric, or glass alternatives. Consider removing vinyl flooring from primary living spaces when renovation is on the table. Use fragrance-free cleaning and laundry products. Increase ventilation to reduce airborne phthalate vapor from vinyl products and off-gassing new materials.
Research by Rudel and colleagues, published in Environmental Health Perspectives, found that a 3-day dietary intervention replacing processed and packaged foods with fresh, organic foods reduced urinary phthalate metabolites by roughly 50% and BPA by roughly 66%. Meaningful exposure reduction, achievable through dietary and product choices, occurring within days rather than months — because both BPA and phthalates have short biological half-lives, hours to 1-2 days.
The Obesity and Metabolic Connection
One of the more surprising dimensions of BPA and phthalate research is the emerging connection to metabolic dysregulation — obesity, insulin resistance, type 2 diabetes. The concept of “obesogens” — chemicals that promote fat accumulation and metabolic dysfunction through endocrine disruption — was proposed by Bruce Blumberg at UC Irvine and has since gathered support from a growing body of animal and human research.
BPA activates PPARγ, the peroxisome proliferator-activated receptor gamma, a nuclear receptor that promotes adipocyte differentiation and lipid storage. At low doses in animal studies, BPA has been shown to increase fat cell size and number, alter insulin sensitivity, and dysregulate pancreatic beta cell function. Human epidemiological research has found associations between urinary BPA and obesity, waist circumference, and markers of insulin resistance across multiple large studies, including NHANES analyses.
Phthalates show similar metabolic associations. Research has found associations between phthalate metabolites and insulin resistance, elevated blood glucose, higher body mass index, and altered lipid profiles. The mechanisms likely involve PPARγ activation and disruption of thyroid hormone signaling — thyroid hormone is a critical regulator of metabolic rate, and phthalates’ anti-thyroid effects may contribute to the metabolic dysfunction seen in the epidemiological studies.
The obesity connection is particularly provocative because it raises the possibility that the dramatic rise in obesity rates over the past 40 years — during the same period BPA and phthalate use expanded enormously — may partly reflect chemical contributions to metabolic dysregulation that conventional diet-and-exercise explanations don’t fully account for. Not to say diet and physical activity don’t matter enormously. They do. But men struggling with metabolic health despite good dietary practices and regular exercise should consider whether chronic endocrine disruptor exposure is acting as a headwind undermining the effort. Reducing BPA and phthalate exposure is part of a comprehensive metabolic health strategy, not a replacement for the foundational practices.
Parabens: The Preservative Problem in Personal Care
Parabens — methylparaben, propylparaben, butylparaben, ethylparaben — are preservatives used in the vast majority of conventional personal care products to prevent bacterial and fungal growth. Effective preservatives, with a long safety track record in acute and subacute toxicity testing. Also estrogenic, detectable in the urine and breast tissue of virtually all tested Americans, and the subject of ongoing debate about their contribution to the endocrine disruption landscape.
The estrogenic potency of parabens is generally lower than BPA’s — roughly 10,000 to 100,000 times weaker than estradiol for the most common one, methylparaben. But skin absorption of parabens from personal care products is more direct than dietary BPA exposure, and the daily quantity of paraben-containing product applied to skin can be substantial. Research has found parabens in human breast tissue, with concentrations highest in the upper outer quadrant — the area closest to the underarm, where antiperspirants and deodorants get applied.
The association between parabens and breast cancer remains contested. Parabens have been detected in breast tumors, and their estrogenic activity provides a biological mechanism for concern, but epidemiological evidence of a causal relationship hasn’t been established. The precautionary principle — choosing paraben-free personal care products where good alternatives exist — is a reasonable response to this uncertainty, given that paraben-free formulations are widely available at comparable performance and cost.
Reading personal care product labels for parabens has become much more practical as the paraben-free market has expanded. Most natural and organic personal care lines avoid parabens, using alternatives like phenoxyethanol, sodium benzoate, potassium sorbate, or vitamin E as preservatives instead. The EWG Skin Deep database rates parabens as moderate-concern ingredients and can help identify specific product alternatives.
Men and Endocrine Disruptors: A Specific Concern
While BPA and phthalate concerns are universal, men face specific reproductive and hormonal vulnerabilities that make these exposures particularly relevant to a men’s health focus. The anti-androgenic effects of phthalates operate through suppression of testosterone synthesis — directly relevant to men’s hormonal health and reproductive function.
Multiple epidemiological studies have found inverse associations between phthalate metabolite concentrations in urine and testosterone levels in adult men. A study in the International Journal of Andrology found that men with higher urinary concentrations of specific phthalate metabolites had lower testosterone levels, higher luteinizing hormone levels suggesting compensatory pituitary signaling, and a lower free androgen index. Effect sizes are modest at typical population exposure levels, but consistent across multiple studies and consistent with the biological mechanism of phthalate-induced Leydig cell suppression demonstrated in animal studies.
Sperm quality is another male-specific endpoint. Studies have found associations between phthalate metabolite levels and reduced sperm concentration, reduced sperm motility, increased sperm DNA fragmentation, and altered sperm morphology. Given that male factor infertility is involved in roughly 50% of couples experiencing fertility difficulty, and given that sperm quality parameters have declined significantly across the Western world over recent decades, the potential contribution of phthalate exposure to declining male reproductive function is a legitimate area of scientific and public health concern.
BPA has male-specific effects too, beyond the general estrogenic concerns. Research has found associations between urinary BPA and lower sperm concentration, reduced sperm vitality, and higher DNA damage in sperm from men with higher BPA exposure. A study in Fertility and Sterility found BPA associated with DNA strand breaks in sperm at concentrations commonly found in American men. The mechanism likely involves oxidative stress in the testes combined with BPA’s estrogenic disruption of testicular function.
Cumulative Endocrine Disruption: The Whole Exceeds the Sum
BPA, phthalates, and parabens don’t exist in isolation — they’re part of a broader chemical mixture Americans are exposed to continuously. Other endocrine-disrupting compounds in the typical exposure landscape include PFAS (thyroid disruptors), pesticides with estrogenic or anti-androgenic properties, triclosan (an antimicrobial with endocrine-disrupting properties, now largely phased out but still found in some products), UV filters in sunscreens (some oxybenzone and other UV filters show hormonal activity), and flame retardants in furniture and electronics.
The combined endocrine-disrupting exposure from all these compounds simultaneously has never been comprehensively assessed for cumulative hormonal effects. Regulatory assessments focus on individual compounds against individual safety thresholds, missing the combined signal entirely. Research by Ana Soto and Carlos Sonnenschein at Tufts, and by others working on mixture effects, has demonstrated that combinations of endocrine disruptors at concentrations that produce no effect individually can produce significant effects in combination — what toxicologists call “something from nothing” effects.
This cumulative perspective explains why comprehensive product substitution — replacing multiple sources of endocrine-disrupting chemicals simultaneously rather than addressing only one category — produces greater effects than any single product swap would suggest based on individual compound potency. Switching to glass containers, fragrance-free products, paraben-free formulations, and PFAS-free cookware simultaneously removes multiple contributors to cumulative endocrine disruption load, with the combined effect substantially larger than any individual change.
The cumulative endocrine disruption framework also explains why some individuals experience more significant health effects than others despite similar individual compound exposure levels — individual variation in receptor sensitivity, metabolic capacity for xenobiotic clearance, and the specific mix of compounds encountered all mean the same individual compound levels can produce very different cumulative hormonal effects depending on the complete exposure profile. Personalized assessment of endocrine-disrupting compound exposure — using urine metabolite testing for the major compounds — provides a more complete picture than any single compound assessment can offer.
BPA and Phthalates in Children: The Developmental Imperative
Children face amplified BPA and phthalate exposure through several biological and behavioral factors, and their developing systems are more sensitive to hormonal disruption than adult systems. Pediatric endocrinologists have been among the most vocal voices calling for stronger regulatory action on endocrine-disrupting chemicals, reflecting the clinical reality of seeing the consequences of disrupted hormonal development in their patients.
Children have higher food intake relative to body weight than adults, resulting in higher daily exposure per kilogram from the same foods. They spend time on floors and put objects in their mouths, increasing exposure to phthalate-containing dust from vinyl flooring and soft plastic toys. They use more personal care products per body weight and are more likely to have products applied to sensitive skin that absorbs chemicals more readily than adult skin.
The developmental timing of BPA and phthalate exposure matters enormously. Prenatal exposure during organogenesis and fetal programming, infant exposure during brain development and immune system maturation, and pubertal exposure during the second major hormonal programming window all represent distinct vulnerability periods where endocrine disruption can produce lasting effects into adult life. Research has found that the same exposure level produces different effects depending on when in development it occurs, with prenatal and early postnatal exposures producing more lasting effects than equivalent adult exposures.
Practical priorities for families with young children: switch to glass or stainless steel feeding containers and bottles. Choose fragrance-free baby care products. Avoid soft PVC bath toys and prefer silicone or rubber alternatives. Reduce canned food consumption in favor of fresh or glass-jarred alternatives. Wash hands before eating to interrupt hand-to-mouth contact with phthalate-containing dust. Simple, inexpensive measures, and they reflect what the developmental endocrinology literature actually supports.
You’ve been conducting an experiment on your hormonal system for decades without knowing it — using products that actively interfere with the chemical signals governing metabolism, reproduction, development, and behavior. The clinically relevant point is that the experiment ends the day you change your products and containers. Your body clears these compounds within days of stopping exposure.
Common Questions About BPA and Phthalate Exposure
- Are children more vulnerable to BPA and phthalate exposure than adults? Yes, significantly. Children have higher food intake relative to body weight, put objects in their mouths, spend time on floors near phthalate-containing vinyl surfaces, and sit in developmental windows — infancy, early childhood, puberty — where hormonal signaling is most critical and disruption carries the most lasting consequences. Pregnant women are another high-priority group, given fetal programming effects during critical developmental windows that can’t be undone once passed.
- Is “fragrance-free” the same as “unscented”? No. “Unscented” products may still contain masking fragrances to cover natural odors — and those can contain phthalates. “Fragrance-free” means no added fragrance compounds, masking fragrances included. Read ingredient lists; if “fragrance” or “parfum” appears, the product contains synthetic fragrance regardless of how it’s marketed. This distinction matters for phthalate reduction, since masking fragrances in “unscented” products can carry the same phthalate compounds as obviously scented products.
- Do plastic cutting boards leach BPA or phthalates? Polypropylene and polyethylene cutting boards — the most common types — don’t contain BPA or phthalates and aren’t a significant concern. Don’t confuse rigid cutting boards with flexible plastic mats, which may use different plastics. Hardwood or bamboo cutting boards sidestep the question entirely and are superior choices for longevity and food safety, given bacterial harbor in knife grooves on plastic.
- Are all plastics equally problematic? No — different plastics have very different chemical compositions. HDPE (recycling #2), polypropylene (#5), and LDPE (#4) are generally considered low-concern for BPA and phthalates. Polycarbonate (#7, some), PVC (#3), and polystyrene (#6) are higher-concern categories. That said, the EHS study showing estrogenic activity in supposedly “safe” plastics under stress conditions suggests minimizing all plastic food contact as a precaution is reasonable, particularly for heated or fatty foods where chemical migration is most significant.
- How quickly does reducing BPA and phthalate exposure lower body levels? Quickly — both have short biological half-lives, hours to 1-2 days, because they’re rapidly metabolized and excreted. Daily exposure matters more than a single past exposure. Reducing ongoing exposure produces rapid reductions in body burden within days for most metabolites. The Rudel intervention study demonstrating 50-66% reductions in just 3 days of dietary change shows how responsive these body burdens are to behavioral change — motivating, not discouraging.
- Should I test for BPA and phthalates in my body? Urine testing for BPA and phthalate metabolites is available through specialty laboratories and some environmental medicine practitioners. Most useful as a baseline and for monitoring response to exposure reduction interventions over time. Because virtually all Americans have detectable levels, a positive result is expected rather than alarming — what matters is the level relative to population averages and its trajectory after implementing changes. Testing motivates and validates behavior change better than speculation does, and the short half-lives mean testing within days of implementing reduction strategies can already show meaningful improvement.
- What about sunscreen ingredients and endocrine disruption? Several chemical UV filters in conventional sunscreens — primarily oxybenzone, octinoxate, and homosalate — show hormonal activity in in vitro and some animal studies. The FDA hasn’t concluded these are unsafe for human use, but has requested more safety data. Mineral sunscreens using zinc oxide or titanium dioxide provide broad-spectrum UV protection without the hormonal activity concerns of chemical filters. For regular daily sunscreen users, mineral formulations are a reasonable precautionary choice, particularly for children and for women during pregnancy. Physical barrier clothing and hats reduce sunscreen exposure altogether for anyone who’d rather minimize application frequency.
The Practical Framework: Applying What’s Known About BPA, the Plastic Hardener With Hormonal Activity, in Real Life
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map